Abeona Therapeutics Inc.
ABEO
$5.39
-$0.01-0.19%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.18M | 82.35M | 57.24M | -44.19M | -63.73M |
| Total Depreciation and Amortization | 3.56M | 3.25M | 3.08M | 3.00M | 2.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -145.69M | -151.90M | -134.52M | -13.70M | 9.20M |
| Change in Net Operating Assets | -5.39M | -8.63M | 8.22M | -4.99M | -4.38M |
| Cash from Operations | -76.33M | -74.93M | -65.98M | -59.88M | -56.02M |
| Capital Expenditure | -7.98M | -7.43M | -5.31M | -3.12M | -2.45M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 18.00K | 18.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 113.00M | 121.78M | 178.12M | -24.11M | -36.81M |
| Cash from Investing | 105.03M | 114.35M | 172.81M | -27.21M | -39.24M |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 20.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.08M | 27.98M | 22.81M | 86.01M | 85.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.00K | -236.00K | -535.00K | -543.00K | -1.49M |
| Cash from Financing | 26.04M | 27.74M | 22.28M | 85.47M | 104.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.74M | 67.16M | 129.11M | -1.62M | 8.88M |